Log In
Print
BCIQ
Print
Print this Print this
 

VN-100

  Manage Alerts
Collapse Summary General Information
Company VentriNova Inc.
DescriptionAdenoviral vector delivering the cyclin A2 (CCNA2) gene
Molecular Target Cyclin A2 (CCNA2)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adenovirus
Latest Stage of DevelopmentPreclinical
Standard IndicationMyocardial infarction (MI)
Indication DetailsTreat myocardial infarction (MI)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today